Text Size

Barrow Nasal Inventory Survey (BNI)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
St. Joseph's Hospital and Medical Center, Phoenix
ClinicalTrials.gov Identifier:
NCT01322945
First received: March 23, 2011
Last updated: January 4, 2012
Last verified: January 2012
History of Changes
  Purpose

The purpose of this study is to evaluate patient nasal outcome following endo-nasal surgery. This type of surgery is conducted for pituitary and skull base tumors. There is no published data on trauma to the nose during surgery and how it impacts nasal functioning. The investigators propose to develop a survey and administer it to patients before and after surgery to learn about their perception of nasal functioning.


Condition
Pituitary Tumors

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of Nasal Outcomes Following Endonasal Surgery for Anterior Skull Base Lesions

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by St. Joseph's Hospital and Medical Center, Phoenix:

Primary Outcome Measures:
  • Patient perception of change in nasal functioning [ Time Frame: 90 days ] [ Designated as safety issue: No ]
    A survery asking patients about the functioning of their nose will be administered to patients before endonasal surgery and ninety days after to determine if there is a change in functioning.


Estimated Enrollment: 100
Study Start Date: January 2011
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Enodnasal surgery, pituitary tumor, nasal functioning
Single cohort of patients undergoing endonasal surgery

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Neurosurgery and endocrinology clinic

Criteria

Inclusion Criteria:

  • Adults with planned endonasal surgery for pituitary tumor or skull base lesion

Exclusion Criteria:

  • Children
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01322945

Locations
United States, Arizona
Barrow Neurological Institute
Phoenix, Arizona, United States, 85013
Sponsors and Collaborators
St. Joseph's Hospital and Medical Center, Phoenix
Investigators
Principal Investigator: Andrew Little, MD Barrow Neurological Institute
  More Information

No publications provided

Responsible Party: St. Joseph's Hospital and Medical Center, Phoenix
ClinicalTrials.gov Identifier: NCT01322945     History of Changes
Other Study ID Numbers: 10BN172
Study First Received: March 23, 2011
Last Updated: January 4, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pituitary Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
 Nervous System Neoplasms
Pituitary Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Hypothalamic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 21, 2013